<code id='BD73DFF9C6'></code><style id='BD73DFF9C6'></style>
    • <acronym id='BD73DFF9C6'></acronym>
      <center id='BD73DFF9C6'><center id='BD73DFF9C6'><tfoot id='BD73DFF9C6'></tfoot></center><abbr id='BD73DFF9C6'><dir id='BD73DFF9C6'><tfoot id='BD73DFF9C6'></tfoot><noframes id='BD73DFF9C6'>

    • <optgroup id='BD73DFF9C6'><strike id='BD73DFF9C6'><sup id='BD73DFF9C6'></sup></strike><code id='BD73DFF9C6'></code></optgroup>
        1. <b id='BD73DFF9C6'><label id='BD73DFF9C6'><select id='BD73DFF9C6'><dt id='BD73DFF9C6'><span id='BD73DFF9C6'></span></dt></select></label></b><u id='BD73DFF9C6'></u>
          <i id='BD73DFF9C6'><strike id='BD73DFF9C6'><tt id='BD73DFF9C6'><pre id='BD73DFF9C6'></pre></tt></strike></i>

          Home / fashion / explore

          explore


          explore

          author:knowledge    Page View:6924
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In